Psychosocial stress and cardiovascular disease part 2: Effectiveness of the transcendental meditation program in treatment and prevention

Behavioral Medicine

Volumn 28, Issue 3, 2002, Pages 106-123

  Walton, Kenneth G ^a   Schneider, Robert H ^b   Nidich, Sanford I ^b   Salemo, John W ^b   Nordstrom, Cheryl K ^b   Merz, C Noel Bairey ^c  

^a MAHARISHI UNIVERSITY OF MANAGEMENT   (United States)

^b ST JOHN HOSPITAL AND MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cardiovascular disease; Psychosocial stress; Review; Transcendental Meditation

Indexed keywords

ARTICLE; BEHAVIOR THERAPY; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; HUMAN; MENTAL STRESS; META ANALYSIS; PATHOPHYSIOLOGY; PSYCHOSOCIAL CARE; RISK FACTOR; TRANSCENDENTAL MEDITATION; TREATMENT OUTCOME;

CARDIOVASCULAR DISEASES; CAROTID ARTERY DISEASES; DISEASE PROGRESSION; HUMANS; HYPERTENSION; MEDITATION; MYOCARDIAL INFARCTION; PHOBIC DISORDERS; PROGRAM DEVELOPMENT; PSYCHOLOGY; RISK FACTORS;

EID: 0038630874     PISSN: 08964289     EISSN: 19404026     Source Type: Journal    
DOI: 10.1080/08964280209596049     Document Type: Article

References (74)

1. Bairey Merz, C, Dwyer, J, Nordstrom, C, Walton, K, Salerno, J, and Schneider, R., 2002. Psychosocial stress and cardiovascular disease:Pathophysiological links. Behav Med, 27:141–146.
2. Tennant, C C. 2001. Life stress and hypertension. J Cardiovasc Risk, 8:51–56.
3. Penninx, B W, Beekman, A T, Honig, A. 2001. Depression and cardiac mortality:Results from a community based longitudinal study. Arch Gen Psychiatry, 58:221–227.
4. Tennant, C C, and McLean, L., 2000. Mood disturbances and coronary heart disease:Progress in the past decade. Med J Aust, 172:151–152.
5. Rozanski, A, Blumenthal, J A, and Kaplan, J., 1999. Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. Circulation, 99:2192–2217.
6. Bairey Merz, C, and Subramanian, R., 1999. Efficacy of psychosocial interventions and stress management for reduction of coronary artery disease events. Preventive Cardiology, 1:1–6.
7. Linden, W, Stossel, C, and Maurice, J., 1996. Psychosocial interventions for patients with coronary artery disease. Arch Intern Med, 156:745–752.
8. Nunes, E, Frank, K, and Kornfeld, D., 1987. Psychologic treatment for Type A behavior pattern and for coronary artery disease:A meta-analysis of the literature. Psychosom Med, 49:159–173.
9. Polk, D M, Nordstrom, C K, Dwyer, J, Kop, W J, Krantz, D S, Bairey and Merz, C N. 2003. “ Novel psychosocial factors and cardiovascular disease ”. In Risk Factors in Coronary Disease, Edited by:Shah, P K. New York:Marcel Dekker.
10. Frasure-Smith, N, Lesperance, F, Prince, R H. 1997. Randomized trial of home-based psychosocial nursing intervention for patients recovering from myocardial infarction. Lancet, 350:473–479.
11. Jones, D A, and West, R R. 1996. Psychological rehabilitation after myocardial infarction:Multicentre randomised controlled trial. BMJ, 313:1517–1521.
12. Orme-Johnson, D W, and Walton, K G. 1998. All approaches to preventing or reversing effects of stress are not the same. American Journal of Health Promotion, 12:297–299.
13. Murphy, L R. 1996. Stress management in work settings:A critical review of the health effects. American Journal of Health Promotion, 11:112–135.
14. Murphy, M, Donovan, S, and Taylor, E., 1997. The Physical and Psychological Effects of Meditation:A Review of Contemporary Research with a Comprehensive Bibliography 1931–1996, Sausalito, California:Institute of Noetic Sciences.
15. Alexander, C N, Davies, J L, Dixon, C A. 1990. “ Growth of higher stages of consciousness:Maharishi's Vedic psychology of human development. ”. In Higher Stages of Human Development:Perspectives on Adult Growth, Edited by:Alexander, C N, and Langer, E J. 286–341. New York:Oxford University Press.
16. Schneider, R H, Alexander, C N, Salerno, J, Robinson, D, Fields, J, and Nidich, S., 2002. Disease prevention and health promotion in the aging with a traditional system of natural medicine:Maharishi Vedic Medicine (MVM). The Journal of Aging and Health, 14:57–78.
17. Nader, T, Rothenberg, S, Averbach, R, Charles, B, Fields, J, and Schneider, R., 2000. Improvements in chronic diseases with a comprehensive natural medicine approach:A review and case studies. Behav Med, 26:34–46.
18. Walton, K, and Pugh, N., 1995. Stress, steroids, and “ojas”:Neuroendocrine mechanisms and current promise of ancient approaches to disease prevention. Indian J Physiol Pharmacol, 39:3–36.
19. Orme-Johnson, D W, and Farrow, J., 1977. Scientific Research on the Transcendental Meditation Program:Collected Papers, Vol 1, 722Rheinweiler, West Germany:MERU Press.
20. Chalmers, R, Clements, G, Schenkluhn, H, and Weinless, M., 1990. Scientific Research on the Transcendental Meditation Program:Collected Papers, Vols 2–4, Vlodrop, The Netherlands:MVU Press.
21. Wallace, R K, Orme-Johnson, D W, and Dillbeck, M C. 1990. Scientific Research on the Transcendental Meditation Program:Collected Papers, Vol 5, Fairfield, Iowa:MIU Press.
22. Jevning, R, Wallace, R K, and Biedebach, M., 1992. The physiology of meditation:A review. A wakeful hypometabolic integrated response. Neurosci Biobehav Rev, 16:415–424.
23. Hawkins, M A. 2002. Effectiveness of the Transcendental Meditation program in criminal rehabilitation and substance abuse recovery:A review of the research. Journal of Offender Rehabilitation, 36:47–65.
24. Roth, R., 1994. Maharishi Mahesh Yogi's Transcendental Meditation, 90–102. Washington, DC:Primus.
25. Williams, R, Barefoot, J, and Califf, R., 1992. Prognostic importance of social and economic resources among medically treated patients with angiographically documented coronary artery disease. JAMA, 267
26. Julkunen, J, Salonen, R, Kaplan, G, Chesney, M, and Salonen, J., 1994. Hostility and the progression of carotid atherosclerosis. Psychosom Med, 56:519–525.
27. Reed, D M, LaCroix, A Z, Karasek, R A, Miller, D, and MacLean, C A. 1989. Occupational strain and the incidence of coronary heart disease. Am J Epidemiol, 129:495–502.
28. Hlatky, M A, Lam, L C, Lee, K L. 1995. Job strain and the prevalence and outcome of coronary artery disease. Circulation, 92:327–333.
29. Grundy, S M, Pasternak, R, Greenland, P, Smith, S J, and Fuster, V., 1999. AHA/ACC scientific statement:Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations:A statement for healthcare professionals from the American Heart Association and the American College of Cardiology. J Am Coll Cardiol, 34:1348–1359.
30. Schneider, R H, Staggers, F., Alexander, C. 1995. A randomized controlled trial of stress reduction for hypertension in older African Americans. Hypertension, 26:820–827.
31. Alexander, C, Schneider, R, Staggers, F. 1996. A trial of stress reduction for hypertension in older African Americans (Part II):Sex and risk factor subgroup analysis. Hypertension, 28:228–237.
32. Alexander, C N, Langer, E J, Newman, R I, Chandler, H M, and Davies, J L. 1989. Transcendental Meditation, mindfulness, and longevity:an experimental study with the elderly. J Person Soc Psychol, 57:950–964.
33. Wenneberg, S, Schneider, R, Walton, K. 1997. A controlled study of the effects of the Transcendental Meditation program on cardiovascular reactivity and ambulatory blood pressure. Int J Neurosci, 89:15–28.
34. Barnes, V A, Treiber, F A, and Davis, H., 2001. Impact of Transcendental Meditation on cardiovascular function at rest and during acute stress in adolescents with high normal blood pressure. J Psychosom Res, 51:597–605.
35. De Armond, D L. 1996. Effects of the Transcendental Meditation program on psychological, physiological, behavioral and organizational consequences of stress in managers and executives in management, 161Fairfield, Iowa:Maharishi University of Management.
36. Schneider, R, Nidich, S, Salerno, J. 1998. Lower lipid peroxide levels in practitioners of the Transcendental Meditation program. Psychosom Med, 60:38–41.
37. Calderon, R., 2000. Effects of Nonpharmacological Approaches on Cholesterol Levels in Mild Hypertensive African Americans:A Pilot Study of the Transcendental Meditation Program and a Health Education Program, [dissertation] 122Fairfield, Iowa:Maharishi University of Management.
38. Alexander, C N, Robinson, P, and Rainforth, M., 1994. “ Treating and preventing alcohol, nicotine and drug abuse through Transcendental Meditation Technique:A review and statistical analysis ”. In Self Recovery—Treating Addictions Using Transcendental Meditation and Maharishi Ayur-Veda, Edited by:O'Connell, D F, and Alexander, C N. 13–88. New York:Haworth Press.
39. Collins, R, Petro, R, MacMahone, S. 1990. Blood pressure, stroke, and coronary heart disease, part 2, Short-term reductions in blood pressure:Overview of randomized drug trials in their epidemiological context. Lancet, 335:827–838.
40. Collins, P, and Fox, K., 1990. Pathophysiology of angina. Lancet, 335:94–96.
41. Cooper, M J, and Aygen, M M. 1979. Transcendental Meditation in the management of hypercholesterolemia. Journal of Human Stress, 5:24–27.
42. Salonen, J T, Yla-Herttuala, S, Yamamoto, R. 1992. Autoantibody against oxidized LDL and progression of carotid atherosclerosis. Lancet, 339:883–887.
43. Naito, C, Kawamura, M, and Yamamoto, Y., 1990. Lipid peroxides as the initiating factor of atherosclerosis. Ann N Y Academ Sci,:27–45.
44. Berliner, J, Navab, M, Fogelman, A. 1995. Atherosclerosis:Basic mechanisms. Oxidation, inflammation and genetics. Circulation, 91:2488–2496.
45. Matthews, K A, Woodall, K L, and Allen, M T. 1993. Cardiovascular reactivity to stress predicts future blood pressure status. Hypertension, 22:479–485.
46. Kamarck, T W, Jennings, J R, Pogue-Geile, M, and Manuck, S B. 1994. A multidimensional measurement model for cardiovascular reactivity:Stability and cross-validation in two adult samples. Health Psychol, 13:471–478.
47. Eppley, K, Abrams, A I, and Shear, J., 1989. Differential effects of relaxation techniques on trait anxiety:A meta-analysis. J Clin Psychol, 45:957–974.
48. Gaylord, C, Orme-Johnson, D, and Travis, F., 1989. The effects of the Transcendental Meditation technique and progressive muscle relaxation on EEG coherence, stress reactivity, and mental health in black adults. Intern J Neurosci, 46:77–86.
49. Alexander, C N, Rainforth, M V, and Gelderloos, P., 1991. Transcendental Meditation, self actualization, and psychological health:A conceptual overview and statistical meta-analysis. Journal of Social Behavior and Personality, 6:189–247.
50. Ferguson, P C. 1991. “ An integrative meta-analysis of psychological studies investigating the treatment outcomes of meditation techniques ”. In Scientific Research on Maharishi's Transcendental Meditation and TM-Sidhi Programme:Collected Papers, Edited by:Chalmers, R, Clements, G, Schenkluhn, H, and Weinless, M. Vol 4, 2039–2048. Vlodrop, Holland:Maharishi European Research University, MVU Press.
51. Jevning, R, Wilson, A F, and Smith, W R. 1978. Adrenocortical activity during meditation. Hormones and Behavior, 10:54–60.
52. Dillbeck, M C, and Orme-Johnson, D W. 1987. Physiological differences between Transcendental Meditation and rest. American Psychologist, 42:879–881.
53. Michaels, R R, Huber, M J, and McCann, D S. 1976. Evaluation of Transcendental Meditation as a method of reducing stress. Science, 192:1242–1244.
54. Mills, P J, Schneider, R H, Hill, D, Walton, K G, and Wallace, R K. 1990. Beta-adrenergic receptor sensitivity in subjects practicing transcendental meditation. J Psychosom Res, 34:29–33.
55. Alexander, C N, Swanson, G C, Rainforth, M V, Carlisle, T W, Todd, C C, and Oates, R M. 1993. Effects of the Transcendental Meditation program on stress reduction, health, and employee development:A prospective study in two occupational settings. Anxiety, Stress and Coping:An International Journal, 6:245–262.
56. Walton, K G, Pugh, N, Gelderloos, P, and Macrae, P., 1995. Stress reduction and preventing hypertension:Preliminary support for a psychoneuroendocrine mechanism. Journal of Alternative and Complementary Medicine, 1:263–283.
57. Levitsky, D K. 1997. Effects of the Transcendental Meditation program on neuroendocrine indicators of chronic stress, [dissertation] 298Fairfield, Iowa:Maharishi University of Management.
58. MacLean, C, Walton, K, Wenneberg, S. 1997. Effects of the Transcendental Meditation program on adaptive mechanisms:Changes in hormone levels and responses to stress after 4 months of practice. Psychoneuroendocrinology, 22:277–295.
59. Infante, J R, Peran, F, Martinez, M. 1998. ACTH and beta-endor-phin in Transcendental Meditation. Physiol Behav, 64:311–315.
60. Infante, J R, Torres-Avisbal, M, Pinel, P. 2001. Catecholamines in practitioners of the Transcendental Meditation technique. Physio Behav, 72:141–146.
61. Barnes, V A, Treiber, F A, Turner, J R, Davis, H, and Strong, W B. 1999. Acute effects of Transcendental Meditation on hemodynamic functioning in middle-aged adults. Psychosom Med, 61:525–531.
62. Alexander, C, Walton, K, and Goodman, R., 2002. Walpole study of the TM program in maximum security prisoners I:Cross-sectional differences in development and psychopathology. Journal of Offender Rehabilitation, 36:97–125.
63. Castillo-Richmond, A, Schneider, R, Alexander, C. 2000. Effects of stress reduction on carotid atherosclerosis in hypertensive African Americans. Stroke, 31:568–573.
64. Fields, J Z, Walton, K G, Schneider, R H. 2002. Effect of a multimodality natural medicine program on carotid atherosclerosis in older subjects:A pilot trial of Maharishi Vedic Medicine. Am J Cardiol, 89:952–958.
65. Blankenhorn, D H, and Hodis, H N. 1994. Arterial imaging and atherosclerosis reversal. George Lyman Duff Memorial Lecture. Arteriosclerosis & Thrombosis, 14:177–192.
66. Kondwani, K A. 1998. “ Nonpharmacologic treatment of hypertension and hypertensive heart disease in African Americans:A trial of the Transcendental Meditation program and a health education program ”. In Psychology, 130Fairfield, Iowa:Maharishi University of Management.
67. Zamarra, J W, Schneider, R H, Besseghini, I, Robinson, D K, and Salerno, J W. 1996. Usefulness of the Transcendental Meditation program in the treatment of patients with coronary artery disease. Am J Cardio, 78:77–80.
68. Salonen, J T, and Salonen, R., 1993. Ultrasound B-mode imaging in observational studies of atherosclerotic progression. Circulation, 87 (Suppl 2):56–65.
69. Koren, M J, Devereux, R B, Casale, P N, Savage, D D, and Laragh, J H. 1991. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med, 114:345–352.
70. Kondwani, K, Schneider, R H, Alexander, C N. Left ventricular mass regression with the Transcendental Meditation technique and a health education program in hypertensive African Americans. Journal of Social Behavior and Personality, In press
71. Devereux, R B, Okin, P M, and Roman, M J. 1998. Pre-clinical cardiovascular disease and surrogate end-points in hypertension:Does race influence target organ damage independent of blood pressure?. Ethnicity and Disease, 8:138–148.
72. Devereux, R B, Roman, M J, Ganau, A, de Simone, G, Okin, P M, and Kligfield, P., 1994. Cardiac and arterial hypertrophy and atherosclerosis in hypertension. Hypertension, 23:802–809.
73. Devereux, R, and Roman, M., 1992. Hypertensive left ventricular hypertrophy:Pathogenesis, prognostic importance and treatment. CVR & R, August:24–33.
74. Alexander, C N, Barnes, V A, Schneider, R H. 1996. A randomized controlled trial of stress reduction on cardiovascular and all-cause mortality in the elderly:Results of 8 and 15 year follow-ups. Circulation [abstract], 93:629